Warburg Pincus Capital Corp I A (WPCA) 10-Q 13 May 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	May 13, 2022
Document Information [Line Items]
Document Type	10-Q
Document Period End Date	Mar. 31, 2022
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity Registrant Name	Warburg Pincus Capital Corporation I-A
Entity Central Index Key	0001836075
Entity File Number	001-40171
Entity Tax Identification Number	98-1572641
Entity Incorporation, State or Country Code	E9
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Address, Address Line One	450 Lexington Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	212
Local Phone Number	878-0600
Title of 12(b) Security	Class A ordinary shares included as part of the units
Trading Symbol	WPCA
Security Exchange Name	NYSE
Entity Shell Company	true
Amendment Flag	false
Entity Ex Transition Period	false
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant
Trading Symbol	WPCA.U
Security Exchange Name	NYSE
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants included as part of the units
Trading Symbol	WPCA WS
Security Exchange Name	NYSE
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		28,342,178
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		7,085,544

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 875,894	$ 1,237,399
Prepaid expenses	469,544	518,804
Total current assets	1,345,438	1,756,203
Investments held in Trust Account	283,457,536	283,436,447
Total Assets	284,802,974	285,192,650
Current liabilities:
Accounts payable	168,881	193,276
Accrued expenses	1,276,835	1,036,165
Total current liabilities	1,445,716	1,229,441
Derivative warrant liabilities	5,380,270	11,332,920
Deferred underwriting commissions	9,919,751	9,919,751
Total liabilities	16,745,737	22,482,112
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 28,342,178 shares as of March 31, 2022 and December 31, 2021, respectively	283,421,780	283,421,780
Shareholders' Deficit:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of March 31, 2022 and December 31, 2021
Additional paid-in capital
Accumulated deficit	(15,365,252)	(20,711,951)
Total shareholders' deficit	(15,364,543)	(20,711,242)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	284,802,974	285,192,650
Common Class A [Member]
Shareholders' Deficit:
Common stock, value	0
Common Class B [Member]
Shareholders' Deficit:
Common stock, value	$ 709	$ 709

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Temporary equity, par or stated value per share	$ 0.0001	$ 0.0001
Temporary equity shares outstanding	28,342,178	28,342,178
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	500,000,000	500,000,000
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	50,000,000	50,000,000
Common stock shares issued	7,085,544	7,085,544
Common stock shares outstanding	7,085,544	7,085,544
Class A Non Redeemable Common Stock Member [Member]
Common stock shares issued	0	0
Common stock shares outstanding	0	0

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
General and administrative expenses	$ 597,040	$ 140,103
General and administrative expenses—related party	30,000	10,000
Loss from operations	(627,040)	(150,103)
Change in fair value of derivative warrant liabilities	5,952,650	1,860,000
Offering costs associated with derivative warrant liabilities	0	(358,700)
Income from investments held in Trust Account	21,089	869
Net income	$ 5,346,699	$ 1,352,066
Common Class A [Member]
Weighted average shares outstanding	28,342,178	6,388,889
Basic and diluted net income per share	$ 0.15	$ 0.11
Common Class B [Member]
Weighted average shares outstanding	7,085,544	6,250,000
Basic and diluted net income per share	$ 0.15	$ 0.11

Condensed Statements Of Changes

Condensed Statements Of Changes In Shareholders' Deficit - USD ($)	Total	Additional Paid-in Capital [Member]	Retained Earnings (Accumulated Deficit) [Member]	Common Class A [Member]Common Stock [Member]	Common Class B [Member]Common Stock [Member]
Balance at Dec. 31, 2020	$ 11,758	$ 24,281	$ (13,242)	$ 0	$ 719
Balance, Shares at Dec. 31, 2020				0	7,187,500
Excess cash received over the fair value of the private warrants (over-allotment)	1,546,670	1,546,670
Accretion of Class A ordinary shares subject to possible redemption amount (over-allotment), Value	(19,973,134)	(1,570,951)	(18,402,183)
Net income	1,352,066		1,352,066
Balance at Mar. 31, 2021	(17,062,640)	0	(17,063,359)	$ 0	$ 719
Balance, Shares at Mar. 31, 2021				0	7,187,500
Balance at Dec. 31, 2021	(20,711,242)	0	(20,711,951)	$ 0	$ 709
Balance, Shares at Dec. 31, 2021				0	7,085,544
Net income	5,346,699		5,346,699
Balance at Mar. 31, 2022	$ (15,364,543)	$ 0	$ (15,365,252)	$ 0	$ 709
Balance, Shares at Mar. 31, 2022				0	7,085,544

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities:
Net income	$ 5,346,699	$ 1,352,066
Adjustments to reconcile net income to net cash used in operating activities:
Income from investments held in Trust Account	(21,089)	(869)
Change in fair value of derivative warrant liabilities	(5,952,650)	(1,860,000)
Offering costs associated with derivative warrant liabilities	0	358,700
General and administrative expenses paid by related party under promissory note	0	3,053
Changes in operating assets and liabilities:
Prepaid expenses	49,260	(862,419)
Accounts payable	(24,395)	12,500
Accrued expenses	240,670	9,965
Net cash used in operating activities	(361,505)	(987,004)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	0	(250,000,000)
Net cash used in investing activities	0	(250,000,000)
Cash Flows from Financing Activities:
Repayment of note payable to related party	0	(78,045)
Proceeds received from initial public offering, gross	0	250,000,000
Proceeds received from private placement	0	8,000,000
Offering costs paid	0	(5,121,841)
Net cash provided by financing activities	0	252,800,114
Net increase in cash	(361,505)	1,813,110
Cash—beginning of the period	1,237,399	0
Cash—end of the period	875,894	1,813,110
Supplemental disclosure of noncash financing activities:
Offering costs included in accrued expenses	0	253,400
Offering costs paid by related party under promissory note	0	74,992
Deferred underwriting commissions	$ 0	$ 8,750,000

Description of Organization and

Description of Organization and Business Operations	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	Note 1-Description Warburg Pincus Capital Corporation I-A As of March 31, 2022, the Company had not yet commenced operations. All activity for the period from December 1, 2020 (inception) through March 31, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating The Company’s sponsor is Warburg Pincus Capital Corporation I-A Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“IPO Private Placement”) of 5,333,333 warrants (collectively, the “Private Placement Warrants” and, together with the Public Warrants, the “Warrants”), at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of $8.0 million (Note 4). On April 20, 2021, simultaneously with the issuance and sale of the Over-Allotment Units, the Company consummated the sale of an additional 445,624 Private Placement Warrants (the “Over-Allotment Private Placement” and, together with the IPO Private Placement, the “Private Placements”), generating gross proceeds of approximately $668,000. The net proceeds from the Initial Public Offering and the Over-Allotment Units, together with certain of the proceeds from the Private Placements, (approximately $283.4 million in the aggregate) (the “Offering Proceeds”), were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the Offering Proceeds, although substantially all of such proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. Notwithstanding the foregoing, pursuant to the amended and restated memorandum and articles of association adopted upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), in no event will the Company redeem Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, executive officers, directors and director nominees agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or March 9, 2023 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern As of March 31, 2022, the Company had approximately $0.9 million in its operating bank account and a working capital deficit of approximately $0.1 million. The Company’s liquidity needs through March 31, 2022 have been satisfied through a payment of $25,000 from the Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $78,000 from the Sponsor pursuant to the Note (as defined in Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on March 9, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loan. Based on the foregoing, management believes that the Company will have the borrowing capacity from its Sponsor or an affiliate of its Sponsor, or its officers and directors to meet our needs through the consummation of a Business Combination. However, in connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15,

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Note 2-Basis Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of March 31, 2022 and December 31, 2021, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 9). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares is classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, 28,342,178 Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. Under ASC 480-10-S99, The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid-in Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income (loss) per ordinary share does not consider the effect of the Public Warrants underlying the Units sold in the Initial Public Offering (including the consummation of the Over-Allotment) and the Private Placement Warrants to purchase an aggregate of 11,447,393 Class A ordinary shares in the calculation of diluted income (loss) per share, because the exercise of the warrant is contingent upon the occurrence of future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three months ended March 31, 2022 and 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The following tables reflect a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share: For the Three Months Ended Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 4,277,359 $ 1,069,340 Denominator: Basic and diluted weighted average ordinary shares outstanding 28,342,178 7,085,544 Basic and diluted net income per ordinary share $ 0.15 $ 0.15 For the Three Months Ended Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 683,462 $ 668,604 Denominator: Basic and diluted weighted average ordinary shares outstanding 6,388,889 6,250,000 Basic and diluted net income per ordinary share $ 0.11 $ 0.11 Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes”, which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Initial Public Offering	Note 3-Initial On March 9, 2021, the Company consummated its Initial Public Offering of 25,000,000 Units, at $10.00 per Unit, generating gross proceeds of approximately $250.0 million, and incurring offering costs of approximately $14.3 million, of which approximately $8.8 million was for deferred underwriting commissions. On April 16, 2021, the underwriters partially exercised the over-allotment option, and the closing of the issuance and sale of the Over-Allotment Units occurred on April 20, 2021. The issuance by the Company of the Over-Allotment Units, at a price of $10.00 per such units, resulted in total gross proceeds of approximately $33.4 million, and the incurrence of approximately $1.8 million in offering costs, of which approximately $1.2 million was for deferred underwriting commissions. Each Unit consists of one Class A ordinary share and one-fifth

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 4-Related Founder Shares On December 9, 2020, the Sponsor paid an aggregate of $25,000 to cover for certain expenses on behalf of the Company in exchange for issuance of 7,187,500 ordinary shares (the “Founder Shares”). In February 2021, the Sponsor transferred 35,000 Founder Shares to an independent director. The Sponsor agreed to forfeit up to an aggregate of 937,500 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional Units was not exercised in full by the underwriters, so that the Founder Shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On April 16, 2021, the underwriters partially exercised the over-allotment option to purchase the Over-Allotment Units and on April 18, 2021, the over-allotment option on the remaining Units expired unexercised by the underwriters; thus, 101,956 Class B ordinary shares were forfeited by the Sponsor. On July 1, 2021, the Company appointed a new independent director. On the same date, the Sponsor transferred 35,000 Founder Shares to such director. On February 14, 2022, the Company appointed a new independent director. On February 15, 2022, the Sponsor transferred 35,000 Founder Shares to such director. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (1) one year after the completion of the initial Business Combination; and (2) subsequent to the initial Business Combination (x) if the last reported sale price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 5,333,333 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of $8.0 million. On April 20, 2021, simultaneously with the issuance and sale of the Over-Allotment Units, the Company consummated the sale of an additional 445,624 Private Placement Warrants, pursuant to the Over-Allotment Private Placement, generating gross proceeds of approximately $668,000. Each Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Loans On December 9, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders’ discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans. Administrative Services Agreement Commencing on the date that the Company’s securities were first listed on the New York Stock Exchange through the earlier of consummation of the initial Business Combination or its liquidation, the Company agreed to reimburse the Sponsor or an affiliate of the Sponsor for office space, secretarial and administrative services provided to the Company in the amount of $10,000 per month. For the three months ended March 31, 2022 and 2021, the Company incurred expenses of $30,000 and $10,000 under this agreement, respectively. As of March 31, 2022 and December 31, 2021, the Company had accrued approximately $20,000 and $10,000, for services in connection with such agreement on the accompanying condensed balance sheets, respectively. In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket In January 2022, the Company entered into a cost sharing arrangement with a related party.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5-Commitments Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement signed upon the effective date of the Initial Public Offering (the “Registration Rights Agreement”). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $5.0 million and $0.7 million ($5.7 million in the aggregate), paid upon the closing of the Initial Public Offering and the sale of the Over- Allotment Units, respectively. In addition, $0.35 per unit, or approximately $9.9 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Consulting fees The Company has agreements with third party consultants to provide certain advisory services to the Company relating to the identification of and negotiations with potential targets, assistance with due diligence, marketing, financial analyses and investor relations, pursuant to which the consultants have agreed to defer their fees and have payment of such fees to be solely contingent on the Company closing an initial Business Combination. As of March 31, 2022 and December 31, 2021, the Company has incurred approximately $442,000 and $0 in contingent fees pursuant to these agreements. The Company will recognize an expense for these services when the performance trigger is considered probable, which in this case will occur upon the closing of an initial Business Combination. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.​​​​​​​

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	3 Months Ended
	Mar. 31, 2022
Temporary Equity Disclosure [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	Note 6—Class A Ordinary Shares Subject to Possible Redemption The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were 28,342,178 Class A ordinary shares outstanding, all of which were subject to possible redemption. The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets is reconciled on the following table: Gross proceeds from Initial Public Offering $ 283,421,780 Less: Fair value of Public Warrants at issuance (6,738,490 ) Offering costs allocated to Class A ordinary shares subject to possible redemption (15,723,462 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 22,461,952 Class A ordinary shares subject to possible redemption $ 283,421,780

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Note 7-Shareholders’ Preference Shares Class A Ordinary Shares Class B Ordinary Shares Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided that, prior to the initial Business Combination, holders of Class B ordinary shares will have the right to appoint all of the Company’s directors and remove members of the board of directors for any reason, and holders of Class A ordinary shares will not be entitled to vote on the appointment of directors during such time. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted one-to-one.

Warrants

Warrants	3 Months Ended
	Mar. 31, 2022
Warrants and Rights Note Disclosure [Abstract]
Warrants	Note 8-Warrants As of March 31, 2022 and December 31, 2021, the Company had 5,668,436 Public Warrants and 5,778,957 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described below under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable, Redemption of Warrants When the Price Per Class A Ordinary Share Equals Or Exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day Redemption of Warrants When the Price Per Class A Ordinary Share Equals Or Exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; • if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and • if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above. The “fair market value” of Class A ordinary shares shall mean the volume-weighted average price of Class A ordinary shares for the 10 trading days following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 9-Fair The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. March 31, 2022 Description Quoted Prices in Significant Significant Assets: Investments held in Trust Account—money market funds $ 283,457,536 $ — $ — Liabilities: Derivative warrant liabilities—Public warrants $ 2,664,160 $ — $ — Derivative warrant liabilities—Private placement warrants $ — $ 2,716,110 $ — December 31, 2021 Description Quoted Prices in Significant Significant Assets: Investments held in Trust Account—money market funds $ 283,436,447 $ — $ — Liabilities: Derivative warrant liabilities—Public warrants $ — $ — $ 5,611,750 Derivative warrant liabilities—Private placement warrants $ — $ — $ 5,721,170 Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. The estimated fair value of Public Warrants transferred from a Level 3 measurement to a Level 1 measurement during the three months ended March 31, 2022 was $5,611,750. The estimated fair value of the Private Placement Warrants transferred from a Level 3 measurement to Level 2 during the three months ended March 31, 2022 was $5,721,170. There were no transfers to/from Levels 1, 2, and 3 during the year ended December 31, 2021. The following table presents the changes in fair value of Level 3 warrant liabilities: Derivative warrant liabilities at January 1, 2021 $ — Issuance of Public and Private Warrants 12,503,330 Change in fair value of derivative warrant liabilities (1,860,000 ) Derivative warrant liabilities at March 31, 2021 $ 10,643,330 Issuance of Public and Private Warrants—over-allotment 1,147,480 Change in fair value of derivative warrant liabilities (457,890 ) Derivative warrant liabilities at December 31, 2021 $ 11,332,920 Transfer of Public Warrants to Level 1 (5,611,750 ) Transfer of Private Placement Warrants to Level 2 (5,721,170 ) Derivative warrant liabilities at March 31, 2022 $ — The following is a description of the valuation methodology used for assets and liabilities measured at fair value: Investments held in Trust Account: Public Warrants: Private Placement Warrants:

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 10-Subsequent The Company has evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash	Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of March 31, 2022 and December 31, 2021, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 9).
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares is classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, 28,342,178 Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. Under ASC 480-10-S99, The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid-in
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income (loss) per ordinary share does not consider the effect of the Public Warrants underlying the Units sold in the Initial Public Offering (including the consummation of the Over-Allotment) and the Private Placement Warrants to purchase an aggregate of 11,447,393 Class A ordinary shares in the calculation of diluted income (loss) per share, because the exercise of the warrant is contingent upon the occurrence of future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three months ended March 31, 2022 and 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The following tables reflect a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share: For the Three Months Ended Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 4,277,359 $ 1,069,340 Denominator: Basic and diluted weighted average ordinary shares outstanding 28,342,178 7,085,544 Basic and diluted net income per ordinary share $ 0.15 $ 0.15 For the Three Months Ended Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 683,462 $ 668,604 Denominator: Basic and diluted weighted average ordinary shares outstanding 6,388,889 6,250,000 Basic and diluted net income per ordinary share $ 0.11 $ 0.11
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes”, which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Schedule of Basic and Diluted Net Income (loss) Per Share of Ordinary Share	The following tables reflect a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share: For the Three Months Ended Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 4,277,359 $ 1,069,340 Denominator: Basic and diluted weighted average ordinary shares outstanding 28,342,178 7,085,544 Basic and diluted net income per ordinary share $ 0.15 $ 0.15 For the Three Months Ended Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 683,462 $ 668,604 Denominator: Basic and diluted weighted average ordinary shares outstanding 6,388,889 6,250,000 Basic and diluted net income per ordinary share $ 0.11 $ 0.11

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	3 Months Ended
	Mar. 31, 2022
Temporary Equity Disclosure [Abstract]
Summary of the Class A ordinary shares subject to possible redemption reflected on the balance sheet is reconciled	The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets is reconciled on the following table: Gross proceeds from Initial Public Offering $ 283,421,780 Less: Fair value of Public Warrants at issuance (6,738,490 ) Offering costs allocated to Class A ordinary shares subject to possible redemption (15,723,462 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 22,461,952 Class A ordinary shares subject to possible redemption $ 283,421,780

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Summary of assets and liabilities that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. March 31, 2022 Description Quoted Prices in Significant Significant Assets: Investments held in Trust Account—money market funds $ 283,457,536 $ — $ — Liabilities: Derivative warrant liabilities—Public warrants $ 2,664,160 $ — $ — Derivative warrant liabilities—Private placement warrants $ — $ 2,716,110 $ — December 31, 2021 Description Quoted Prices in Significant Significant Assets: Investments held in Trust Account—money market funds $ 283,436,447 $ — $ — Liabilities: Derivative warrant liabilities—Public warrants $ — $ — $ 5,611,750 Derivative warrant liabilities—Private placement warrants $ — $ — $ 5,721,170
Summary of change in the fair value of derivative warrant liabilities	The following table presents the changes in fair value of Level 3 warrant liabilities: Derivative warrant liabilities at January 1, 2021 $ — Issuance of Public and Private Warrants 12,503,330 Change in fair value of derivative warrant liabilities (1,860,000 ) Derivative warrant liabilities at March 31, 2021 $ 10,643,330 Issuance of Public and Private Warrants—over-allotment 1,147,480 Change in fair value of derivative warrant liabilities (457,890 ) Derivative warrant liabilities at December 31, 2021 $ 11,332,920 Transfer of Public Warrants to Level 1 (5,611,750 ) Transfer of Private Placement Warrants to Level 2 (5,721,170 ) Derivative warrant liabilities at March 31, 2022 $ —

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)	Apr. 20, 2021	Apr. 16, 2021	Mar. 09, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Share Price				$ 10
Proceeds from issuance of IPO				$ 0	$ 250,000,000
Deferred underwriting commissions				$ 9,919,751		$ 9,919,751
Class of warrants and rights issued, price per warrant				$ 1.50
Proceeds from issuance of private placement	$ 668,000			$ 0	8,000,000
Payment to acquire restricted investments				$ 0	$ 250,000,000
Restricted investments term				185 days
Minimum net worth to consummate business combination				$ 5,000,001
Percentage of public shares to be redeemed on non completion of business combination				100.00%
Lock in period for redemption of public shares after closing of IPO				24 months
Dissolution expense				$ 100,000
Minimum share price of the residual assets remaining available for distribution				$ 10
Cash				$ 875,894		1,237,399
working capital (deficit)				$ 100,000
Sponsor [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Mimimum public share price due to reductions in the value of the trust assets less taxes payable.				$ 10
Proceeds from unsecured and non-interest bearing promissory note				$ 78,000
Due to related parties current				0		$ 0
Sponsor [Member] | Founder Shares [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from issuance of common stock				$ 25,000
Maximum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Share Price				$ 10
Minimum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of fair market value of target business to asset held in trust account				80.00%
Net tangible assets required for consummation of business combination				$ 5,000,001
Percentage of redeeming shares of public shares without the company's prior written consent				15.00%
Minimum [Member] | Series of Individually Immaterial Business Acquisitions [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of voting interests acquired				50.00%
Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants and rights issued during the period				5,333,333
Class of warrants and rights issued, price per warrant				$ 1.50
Proceeds from issuance of private placement	$ 668,000			$ 8,000,000
IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Offering cost			$ 14,300,000
Deferred underwriting commissions			$ 8,800,000
Payment to acquire restricted investments				$ 283,400,000
IPO [Member] | Public Warrant [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants and rights issued during the period			5,000,000
Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during period shares		3,342,178
Share Price	$ 10	$ 10
Proceeds from issuance of IPO	$ 33,400,000	$ 33,400,000
Offering cost		1,800,000	$ 1,800,000
Deferred underwriting commissions		$ 1,200,000	$ 1,200,000
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants and rights issued during the period	445,624
Common Class A [Member] | IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during period shares			25,000,000
Share Price			$ 10
Proceeds from issuance of IPO			$ 250,000,000

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Income (loss) Per Share of Ordinary Share (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Common Class A [Member]
Numerator:
Allocation of net income	$ 4,277,359	$ 683,462
Denominator:
Basic and diluted weighted average ordinary shares outstanding	28,342,178	6,388,889
Basic and diluted net income per ordinary share	$ 0.15	$ 0.11
Common Class B [Member]
Numerator:
Allocation of net income	$ 1,069,340	$ 668,604
Denominator:
Basic and diluted weighted average ordinary shares outstanding	7,085,544	6,250,000
Basic and diluted net income per ordinary share	$ 0.15	$ 0.11

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
FDIC insured amount	$ 250,000
Restricted investments term	185 days
Unrecognized tax benefits	$ 0		$ 0
Accrued for interest and penalties	$ 0		$ 0
US Government Securities [Member]
Restricted investments term	185 days
Common Class A [Member]
Temporary equity shares outstanding	28,342,178	28,342,178
Common Class A [Member] | Warrant [Member]
Antidilutive securities excluded from computation of earnings per share, amount	11,447,393

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)	Apr. 20, 2021	Apr. 16, 2021	Mar. 09, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Share Price				$ 10
Proceeds from issuance of IPO				$ 0	$ 250,000,000
Deferred underwriting commissions				$ 9,919,751		$ 9,919,751
Public Warrants [Member]
Exercise price of warrant				$ 11.50
IPO [Member]
Offering cost			$ 14,300,000
Deferred underwriting commissions			8,800,000
Over-Allotment Option [Member]
Stock issued during period shares		3,342,178
Share Price	$ 10	$ 10
Proceeds from issuance of IPO	$ 33,400,000	$ 33,400,000
Offering cost		1,800,000	1,800,000
Deferred underwriting commissions		$ 1,200,000	$ 1,200,000
Common Class A [Member]
Stock conversion basis				one-fifth of one
Exercise price of warrant				$ 10
Common Class A [Member] | Public Warrants [Member]
Shares issuable per warrant				1
Exercise price of warrant				$ 11.50
Common Class A [Member] | IPO [Member]
Stock issued during period shares			25,000,000
Share Price			$ 10
Proceeds from issuance of IPO			$ 250,000,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Feb. 15, 2022	Jul. 01, 2021	Apr. 20, 2021	Apr. 16, 2021	Mar. 09, 2021	Dec. 09, 2020	Feb. 28, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Apr. 18, 2021
Related Party Transaction [Line Items]
Class of warrants and rights issued, price per warrant								$ 1.50
Proceeds received from private placement			$ 668,000					$ 0	$ 8,000,000
Minimum lock In period for transfer, assign or sell warrants after completion of IPO								30 days
Proceeds from related party debt					$ 78,000
Debt instrument convertible into warrants								$ 1,500,000
Expenses incurred for the period								30,000	10,000
Administrative Services Agreement [Member]
Related Party Transaction [Line Items]
Expenses incurred for the period								30,000	10,000
Accrued Expenses for services								$ 20,000	$ 10,000
Working Capital Loan [Member]
Related Party Transaction [Line Items]
Debt instrument conversion price								$ 1.50
Due to related parties current								$ 0		$ 0
Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrants and rights issued during the period								5,333,333
Class of warrants and rights issued, price per warrant								$ 1.50
Proceeds received from private placement			$ 668,000					$ 8,000,000
Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Stock issued during period shares				3,342,178
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrants and rights issued during the period			445,624
Sponsor [Member]
Related Party Transaction [Line Items]
Due to related parties current								0		$ 0
Sponsor [Member] | Office Space Administrative and Support Services [Member]
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction								$ 10,000
Sponsor [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Debt Instrument, face amount						$ 300,000
Sponsor [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrant or right, number of securities called by warrants or rights								1
Minimum lock In period for transfer, assign or sell warrants after completion of IPO								30 days
Founder Shares [Member] | IPO [Member]
Related Party Transaction [Line Items]
Common stock, threshold percentage on conversion of shares							20.00%
Founder Shares [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Number of shares forfeited during the period							937,500
Independent Directors [Member] | Founder Shares [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period shares		35,000
Independent Directors [Member] | Founder Shares [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period shares	35,000						35,000
Common Class B [Member] | Founder Shares [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period, value, issued for services						$ 25,000
Stock issued during period shares						7,187,500
Temporary equity shares outstanding											101,956
Common Class A [Member]
Related Party Transaction [Line Items]
Temporary equity shares outstanding								28,342,178		28,342,178
Exercise price of warrant								$ 10
Common Class A [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Exercise price of warrant								11.50
Common Class A [Member] | IPO [Member]
Related Party Transaction [Line Items]
Stock issued during period shares					25,000,000
Common Class A [Member] | Sponsor [Member] | Share Price More Than Or Equals To $12 [Member]
Related Party Transaction [Line Items]
Share transfer, trigger price price per share								$ 12
Number of consecutive trading days for determining share price								20 days
Number of trading days for determining share price								30 days
Threshold number of trading days for determining share price from date of business combination								150 days
Common Class A [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Common stock, threshold percentage on conversion of shares								20.00%

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Apr. 16, 2021	Mar. 09, 2021
Subsidiary, Sale of Stock [Line Items]
Underwriting discount paid per unit	$ 0.20
Underwriting expense paid	$ 5,000,000
Deferred underwriting commission per unit	$ 0.35
Deferred underwriting commissions	$ 9,919,751	$ 9,919,751
Contingent Fees [Member] | Consulting Fees [Member]
Subsidiary, Sale of Stock [Line Items]
Related party transaction, amounts of transaction	442,000	$ 0
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Deferred underwriting commissions			$ 1,200,000	$ 1,200,000
Underwriting discount paid on sale of units	700,000
Underwriting discount paid on sale of units aggregate amount	$ 5,700,000
Over-Allotment Option [Member] | Common Class A [Member]
Subsidiary, Sale of Stock [Line Items]
Overallotment Option Vesting Period	45 days
Common stock shares subscribed but not issued	3,750,000

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Details) - Common Class A [Member] - $ / shares	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Temporary Equity [Line Items]
Temporary equity shares authorized	500,000,000
Temporary equity, par or stated value per share	$ 0.0001	$ 0.0001
Temporary equity voting rights	one
Temporary equity shares outstanding	28,342,178	28,342,178

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject to Possible Redemption - Summary of the Class A ordinary shares subject to Possible Redemption Reflected on the Balance Sheet is Reconciled (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Temporary Equity [Line Items]
Gross proceeds from Initial Public Offering	$ 283,421,780
Fair value of Public Warrants at issuance	(6,738,490)
Offering costs allocated to Class A ordinary shares subject to possible redemption	(15,723,462)
Accretion on Class A ordinary shares subject to possible redemption amount	22,461,952
Class A ordinary shares subject to possible redemption	$ 283,421,780	$ 283,421,780

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Detail) - $ / shares	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Class of Stock [Line Items]
Common stock shares authorized	500,000,000	500,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock issued	28,342,178	28,342,178
Common stock outstanding	28,342,178	28,342,178
Temporary equity shares outstanding	28,342,178	28,342,178
Stock conversion basis	one-fifth of one
Common Class A [Member] | Founder Shares [Member]
Class of Stock [Line Items]
Common stock, threshold percentage on conversion of shares	20.00%
Stock conversion basis	one vote for each share
Common Class B [Member]
Class of Stock [Line Items]
Common stock shares authorized	50,000,000	50,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock issued	7,085,544	7,085,544
Common stock outstanding	7,085,544	7,085,544

Warrants - Additional Informati

Warrants - Additional Information (Detail) - $ / shares	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Class of Warrant or Right [Line Items]
Minimum lock In period for transfer, assign or sell warrants after completion of IPO	30 days
Share price	$ 10
Share Price Equal or Less 9.20 per dollar [Member]
Class of Warrant or Right [Line Items]
Class of warrant or right, exercise price adjustment percentage higher of market value	115.00%
Share Price Equal or Exceeds $18.00 per dollar [Member]
Class of Warrant or Right [Line Items]
Share redemption trigger price	$ 18
Class of warrants, redemption notice period	30 days
Share Price Equal or Less $10.00 per dollar [Member]
Class of Warrant or Right [Line Items]
Share redemption trigger price	$ 10
Common Class A [Member]
Class of Warrant or Right [Line Items]
Exercise price of warrant	$ 10
Class of warrants, redemption notice period	10 days
Common stock, convertible, conversion price	$ 0.361
Common Class A [Member] | Share Price Equal or Less 9.20 per dollar [Member]
Class of Warrant or Right [Line Items]
Exercise price of warrant	9.20
Share redemption trigger price	$ 9.20
Minimum percentage gross proceeds required from issuance of equity	60.00%
Class of warrant or right, minimum notice period for redemption	20 days
Common Class A [Member] | Share Price Equal or Exceeds $18.00 per dollar [Member]
Class of Warrant or Right [Line Items]
Exercise price of warrant	$ 18
Class of warrants, redemption price per unit	$ 0.01
Class of warrants, redemption notice period	30 days
Share price	$ 18
Number of consecutive trading days for determining share price	20 days
Number of trading days for determining share price	30 days
Common Class A [Member] | Share Price Equal or Less $10.00 per dollar [Member]
Class of Warrant or Right [Line Items]
Exercise price of warrant	$ 10
Class of warrant or right, exercise price adjustment percentage higher of market value	180.00%
Class of warrants, redemption price per unit	$ 0.10
Class of warrants, redemption notice period	30 days
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Number of warrants or rights outstanding	5,668,436	5,668,436
Warrants exercisable term from the date of completion of business combination	30 days
Warrants exercisable term from the closing of IPO	12 months
Minimum lock in period for sec registration from date of business combination	15 days
Minimum lock in period to become effective after the closing of the initial business combination	60 days
Exercise price of warrant	$ 11.50
Warrants and rights outstanding, term	5 years
Public Warrants [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Exercise price of warrant	$ 11.50
Private Placement Warrants [Member]
Class of Warrant or Right [Line Items]
Number of warrants or rights outstanding	5,778,957	5,778,957
Private Placement Warrants [Member] | Share Price Equal or Less $10.00 per dollar [Member]
Class of Warrant or Right [Line Items]
Share price	$ 18
Private Placement Warrants [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Exercise price of warrant	$ 11.50

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Level 1 [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account	$ 283,457,536	$ 283,436,447
Level 1 [Member] | Derivative Financial Instruments, Liabilities [Member] | Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative warrant liabilities	2,664,160
Level 2 [Member] | Derivative Financial Instruments, Liabilities [Member] | Private Placement Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative warrant liabilities	2,716,110
Level 3 [Member] | Derivative Financial Instruments, Liabilities [Member] | Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative warrant liabilities	0	5,611,750
Level 3 [Member] | Derivative Financial Instruments, Liabilities [Member] | Private Placement Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative warrant liabilities	$ 0	$ 5,721,170

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Change in the Fair Value of Derivative Warrant Liabilities (Detail) - Level 3 [Member] - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative warrant liabilities at Beginning balance	$ 11,332,920	$ 0	$ 0
Issuance of Public and Private Warrants		12,503,330
Change in fair value of derivative warrant liabilities		(1,860,000)	(457,890)
Derivative warrant liabilities at Ending Balance	0	$ 10,643,330	11,332,920
Public Warrants [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Transfer of Warrants to Levels 1 and 2	(5,611,750)
Private Placement Warrants [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Transfer of Warrants to Levels 1 and 2	$ (5,721,170)
Over-allotment [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Issuance of Public and Private Warrants			$ 1,147,480

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2022USD ($)
Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Estimated fair value of warrants transferred from level 3 to level 1 measurement	$ 5,611,750
Private Placement Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Estimated fair value of warrants transferred from level 3 to level 2 measurement	$ 5,721,170